Primary chemotherapy: how does it compare with surgery?
Small-volume metastatic nonseminoma primary chemotherapy following orchidectomy cures the same high proportion of patients as does retroperitoneal lymph node dissection (RPLND). The 5-year survival in 122 patients treated at the Royal Marsden Hospital was 97%; 35 of these men had postchemotherapy lymphadenectomy and only 5 suffered loss of ejaculation. Primary chemotherapy is a reasonable alternative to RPLND for stage II testicular nonseminoma.